Accumulating evidence from both genetic and clinico-pharmacological studies suggests that D-serine, an endogenous coagonist to the NMDA subtype glutamate receptor, may be implicated in schizophrenia (SZ). Although an association of genes for D-serine degradation, such as D-amino acid oxidase and G72, has been reported, a role for D-serine in SZ has been unclear. In this study, we identify and characterize protein interacting with C-kinase (PICK1) as a protein interactor of the D-serine synthesizing enzyme, serine racemase (SR). The binding of endogenous PICK1 and SR requires the PDZ domain of PICK1. The gene coding for PICK1 is located at chromosome 22q13, a region frequently linked to SZ. In a case-control association study using well-characterized Japanese subjects, we observe an association of the PICK1 gene with SZ, which is more prominent in disorganized SZ. Our findings implicating PICK1 as a susceptibility gene for SZ are consistent with a role for D-serine in the disease.
Introduction
Glutamate neurotransmission has been implicated in schizophrenia (SZ). [1] [2] [3] [4] [5] Activation of NMDA receptors requires stimulation of a glycine site in addition to the glutamate recognition site. 6 Recent studies establish D-serine as an endogenous ligand for this site in many areas of the brain, while glycine itself may be the endogenous ligand in certain regions. [7] [8] [9] [10] [11] [12] [13] D-serine is generated from L-serine by the enzyme serine racemase (SR) that is localized to a population of glial astrocytes, which ensheathe synapses in brain regions enriched in NMDA receptors. 14, 15 Glutamate released from neurons activates glutamate receptors of the AMPA subtype on these astrocytes triggering the release of D-serine. 7 Treatment of SZ with D-serine, D-cycloserine, or glycine together with classic neuroleptics ameliorates some symptoms. [16] [17] [18] [19] [20] Genetic association studies also implicate D-serine in SZ. In several independent studies, genes coding for the D-serine degrading enzyme, D-amino acid oxidase (DAO), and its potential regulator G72, are associated with SZ. [21] [22] [23] [24] [25] [26] [27] We have explored a role for D-serine synthesis in SZ. As the gene for SR itself is located to chromosome 17, which has been neither linked to nor associated with SZ, 28 we focused on binding partners for SR with some relationship to SZ. Here, we report binding of SR to protein interacting with C-kinase (PICK1), whose gene is located at chromosome 22q13.1. The chromosome 22q11-13 region displays linkage to SZ, [29] [30] [31] [32] [33] [34] and a cluster of genes in the region are associated with SZ, including catechol-O-methyltransferase, 35, 36 ZDHHC8, 37 and proline dehydrogenase. [38] [39] [40] We also demonstrate an association of the PICK1 gene with disorganized SZ.
Materials and methods
Yeast two-hybrid screening Yeast two-hybrid screening was performed using a human adult whole brain cDNA library subcloned into the pPC86 vector, which contains the GAL4 transactivation domain. 41 The bait was the full length of human SR subcloned into pDBlue vector, which contains the GAL4 DNA binding domain. Over one million independent clones were screened, and positively interacting proteins were identified by selecting for Leu þ , Trip þ , His þ growth phenotype. Positive clones were further evaluated for b-galactosidase expression. All of the constructs were from PCR products subcloned in frame into pPC86 or pDBlue vectors and were confirmed by sequencing. PICK1 K27A/D28A mutant was generated as described previously. 42 Cell culture and transfection Cultured astrocytes were prepared from the cerebral cortex of 2-to 6-day-old postnatal mice as described. 43 Cultured astrocytes and HEK293 cells were maintained in DMEM media supplemented with 2 mM Lglutamine and 10% fetal bovine serum. Transfection of hemagglutinin (HA)-tagged SR and/or myc-tagged PICK1 was carried out by calcium phosphate method.
In vitro binding assay PICK1, PICK1 mutants or GAPDH was fused to glutathione-S-transferase (GST) by subcloning into a pGEX vector (Amersham Biosciences). Extracts of Escherichia coli strain BL21 were used as a source of GST fusion proteins. Lysates of HEK293 cells transiently transfected with a HA-tagged SR cDNA and purified GST-fusion protein were incubated in 50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM phenylmethane sulfonylfluoride (PMSF), and 1 mM 1,4-dithiothreitol, and a protease inhibitor mixture (Roche) for 45 min. HA-tagged SR bound to GST-fusion protein was precipitated with glutathione sepharose beads (Amersham Biosciences). The protein precipitates were analysed with SDS-PAGE, followed by Western blotting with a polyclonal antibody against HA (Medical and Biological Laboratories).
Co-immunoprecipitation
Cultures astrocytes were homogenized in buffer containing 50 mM Tris-HCl pH 7.8, 10% glycerol, 1 mM PMSF and a protease inhibitor cocktail (Sigma).
Lysates were centrifuged at 10 000 g, and the supernatant containing 500 mg of proteins was precleared with mouse immunoglobulin with Pansorbin (EMD Biosciences). Cleared lysates were immunoprecipitated with an anti-SR monoclonal antibody (BD Biosciences) overnight at 41C. The immunoprecipitates and input were analyzed in SDS-PAGE followed by immunoblotting with anti-SR and anti-PICK1 antibodies (Santa Cruz biotechnology). Both the anti-SR and anti-PICK1 antibodies recognize the single band at the expected size of the proteins in the Western blotting (Figure 2b ).
Immunocytochemistry
Immunofluorescent cell staining was carried out as described. 41 In brief, cells were fixed with 3.7% paraformaldehyde in PBS, and permealized with 0.1% Triton X-100. Primary antibodies used were follows: a polyclonal rabbit anti-HA antibody (Medical and Biological Laboratories) and a monoclonal mouse anti-myc antibody (Calbiochem), which are commercially available as specific antibodies. Secondary antibodies used for fluorescence were follows: a Rhodamine Red-X conjugated anti-rabbit IgG antibody and a cyanine Cy2 conjugated anti-mouse antibody (Jackson ImmunoResearch).
Subjects in association study
The subjects in the present case-control association study were 200 unrelated Japanese SZ patients (108 men and 92 women; mean age 46.379.9 years) fulfilling the international statistical classification of the disease, revision 10 (ICD-10) diagnostic criteria for SZ, and 200 age-matched Japanese normal controls (91 men and 109 women; mean age 43.3710.9 years) who had no positive personal or familial history of major psychiatric disorders. Patients in this study retained their diagnosis by the ICD-10 for at least 3 years indicating a high reliability of their initial diagnosis. Trained psychiatrists who did not participate in the genetic association study diagnosed patients. Population stratification was discussed in the previous studies using the same sample set. 44, 45 For further analysis, the SZ patients were subdivided into 90 patients of disorganized type and 110 of nondisorganized type according to the criteria set out in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Disorganized type (DSM-IV: 295.10) were previously diagnosed as hebephrenic type (ICD-10: F20.1), and nondisorganized type as paranoid (F20.0), catatonic (F20.2), or undifferentiated type (F20.3), respectively. 44, 45 Assessment for diagnosis and subtype of SZ were performed by trained psychiatrists who did not participate in the genetic analyses, on the basis of all available information including hospital notes. After being provided with a complete description of the study, written informed consent to participate was obtained from all participants prior to examination. The genetic association study was approved by the Ethics Committee in Okayama and Tottori Universities in Japan.
Sequencing and genotyping
Genomic DNA was extracted from peripheral leukocytes using a standard phenol/CHCL3 procedures. 44, 45 First, five SZ and five control subjects were randomly selected for direct sequencing of all known coding exons of PICK1 as well as 50 bp of intronic sequences flanking each exon. By sequencing, we identified a total of four intronic single-nucleotide polymorphisms (SNPs) including two previously reported and two novel polymorphisms. Of these, we chose to genotype the two previously reported common SNPs (rs713729 and rs2076369) likely to be informative for genetic association testing. These SNPs were selected for genotyping because they crossed our threshold of 15% for the minor allele frequency in the Japanese population. The two novel SNPs we identified were rare and unlikely to be informative for genetic association (sequence data not shown). The third SNP we genotyped (rs3952) is an intronic SNP that was previously reported by Hong et al. 46 Specific marker locations were determined using the May 2004 Freeze of the UCSC Genome Browser (http:// genome.ucsc.edu/). All samples were genotyped by using the Taqman assay and the ABI 7900HT sequence detection system (Applied Biosystems). All probes and primers were designed by the Assayby-Designt service of Applied Biosystems. After we genotyped rs713729 and rs2076369, we verified the accuracy of our genotyping method by comparing the Taqman genotypes to the direct sequencing results we obtained previously. We found that there was 100% agreement for both markers between their Taqman genotypes and our sequencing data, indicating a high degree of accuracy of the Taqman genotyping method. The high degree of agreement between direct sequencing and Taqman genotyping was also demonstrated. 47 It is consistently reported that the Taqman assay produces greater than 99.5% concordance with independent methods.
Statistics
The statistical significance of differences in the genotype distribution and allele frequency between patients and controls was assessed by a w 2 test or Fisher's exact test at a significance level of 0.05. Statview software (SAS Institute Inc.) was used for these analyses. Marker-to-marker linkage disequilibrium (LD), haplotype block structure, and association tests for single SNPs and haplotypes of the PICK1 gene were analyzed by Haploview, version 3.2. 48 Single markers and haplotypes were permuted 1000 times to correct for bias due to multiple testing. Haplotype association results were confirmed using COCAPHASE (Dudbridge 2003; http://www.hgmp. mrc.ac.uk/Registered/Option/unphased.html). We also used COCAPHASE to obtain global P-values for 2-and 3-marker haplotype tests.
Results

Binding of SR to PICK1
We used human SR as a bait in yeast two-hybrid screening with a human adult hippocampal cDNA library (Figure 1 ). Out of one million independent clones, we observe five positive clones for PICK1, in addition to one positive clone for glutamate receptor interacting protein (GRIP), which we previously reported to bind SR in rodent cDNA library. 49 PICK1 contains a prominent PDZ domain, a motif associated with protein-protein interactions. The PDZ domain of PICK is responsible for its binding to protein kinase C. 42, 50 PICK1 also contains a coiled-coil domain. To ascertain domains of PICK1 responsible for binding to SR, we employed yeast two-hybrid analysis. Mutation of a lysyl-aspartate dipeptide within the PDZ domain of PICK1, which is critical for protein kinase C binding, to alanyl-alanine abolishes binding of PICK1 to SR, establishing the importance of the PDZ domain for the binding interaction. Deletion of the coiled-coil domain of PICK1 also abolishes binding to SR.
To examine the possibility that PICK1 binds to the C-terminus of SR, we generated a mutant of SR with tyrosine added to the C-terminus to obscure the Cterminal valine. This modification abolishes binding of SR and PICK1, establishing that the C-terminus of SR is critical for its binding to PICK1.
To confirm the interactions of SR and PICK1 biochemically, we transfected HEK293 cells with HA-tagged SR (HA-SR) and demonstrate its binding in cell lysates to PICK1 tagged with glutathione-Stransferase (GST-PICK1) and assessed the binding of GST-PICK1 and HA-SR (Figure 2a) . The PDZ domain is critical, as mutation of the lysyl-aspartate of PICK1 abolishes the binding. The importance of the coiledcoil domain is confirmed, as its deletion from PICK1 also abolishes binding. To establish that PICK1 and SR interact physiologically in brain tissue, we utilized primary glial cultures and demonstrate coimmunoprecipitation of the two proteins at endogenous level (Figure 2c) .
For SR and PICK1 to interact physiologically, they should have similar localizations. We transfected SR and PICK1 into HEK293 cells and examined their localization by immunofluorescence (Figure 3 ). Both SR and PICK1 occur exclusively in the cytoplasm in a similar granular pattern. Staining of primary glial cultures with antibodies to native SR and PICK1 resembles the results obtained in the HEK293 cells (data not shown).
Association of PICK1 with disorganized SZ
In an independent study, Hong et al. 46 conducted a case-control study in a Chinese population genotyping a SNP that occurs within the PICK1 gene (rs3952) and observed a mild association of the SNP and SZ. Here, we have conducted an association study of three independent SNPs, including the SNP utilized by Hong et al., 46 in Japanese SZ (Figure 4 ). To identify appropriate SNPs for analysis, first we sequenced all the 13 coding exons of PICK1 along with 50 base adjacent intronic sequences, and selected two SNPs, according to the criteria that their minor allele frequencies are 15% or greater in our Japanese population. These two SNPs (rs713729 and rs2076369) occur in the PDZ domain as does the SNP examined by Hong et al. 46 As indicated by Haploview, all the SNPs follow Hardy-Weinberg equilibrium (rs713729, P = 0.666; rs3952, P = 1.0; rs2076369, P = 0.802). There is almost complete LD (disequilibrium coefficient D 0 = 0.99, 0.07 > r 2 > 0.40) in the region spanning approximately 7000 bases, including these three SNPs, indicating that the markers all cosegregate through recombination events.
All case-control association tests were performed using 1000 permutations in Haploview, which randomizes affection status for single markers and haplotypes in blocks with each permutation to control for the possibility of bias due to multiple testing. In our tests of individual markers, we find weak evidence for an overall difference in allele distribution between our 200 cases and 200 controls for one SNP, rs2076369 (P = 0.080) in intron 4 of the PICK1 gene (Table 1) . Given the risk allele ('T' allele) frequency for the rs2076369 SNP of 0.382, our sample of 200 cases and 200 controls has the ability to detect an effect size with a relative risk (RR)1 (heterozygote) of 2.0 and a RR2 (homozygote) of 3.1 with 80% power, assuming a disease prevalence of 1%, which was estimated by the Genetic Power Calculator available on-line (http:// statgen.iop.kcl.ac.uk/gpc/). 51 We subdivided our cases further into 'disorganized' (n = 90) and 'nondisorganized' (n = 110), and performed single-marker analyses for each group as compared all controls (n = 200). This is the only subdivision of the cases in this study, based on our hypothesis that 'disorganized' SZ may have a preferential susceptibility to genetic risk factors related to glutamatergic neurotransmission. The subset displays poorer prognosis with more prominent negative symptoms. In the 'disorganized' cases, we observe a statistically significant difference in allele distribution for two SNPs, rs3952 (P = 0.050) and rs2076369 (P = 0.012) in introns 3 and 4 of the PICK1 gene, respectively. We find no evidence in support of a difference in allele distribution between 'nondisorganized' cases and controls for any of our three markers. PICK1 and schizophrenia K Fujii et al (P = 0.056-0.092) between cases and controls in every 2-and 3-marker combination. Our haplotype analyses of 'disorganized' cases controls reveal a statistically significant association for the same risk haplotype T-A-T (P = 0.010-0.015) for every combination of markers as well as another differentially distributed haplotype T-G-G with mild significance (P = 0.050-0.087). We do not detect association of haplotypes in 'non-disorganized' cases as compared to controls. Taken together, these results suggest that the genetic variation in the PICK1 gene may primarily reflect 'disorganized' cases.
Discussion
In the present study we have demonstrated a physiologic protein interaction of PICK1 with SR. The only other known protein interactor with SR is GRIP whose binding to SR elicits a five-fold augmentation of D-serine synthesis and release. 49 Physiologic activation of AMPA receptors on glia markedly enhances SR activity and D-serine release. How PICK1 and GRIP interact to regulate SR is unclear. In neurons, coordinated regulation of AMPA receptors by PICK1 and GRIP is dependent on phosphorylation status of the receptor. 52 We found an association of three SNPs in PICK1 with 'disorganized' but not with 'nondisorganized' SZ ( Figure 5 ). The selectivity of association with only one subtype of SZ, comprising about half the patients studied here, suggests the specificity of this relationship. 'Disorganized' patients generally represent a more severely ill population.
In an independent investigation, Hong et al.
46
observed a mild association of SZ with a single SNP (P = 0.025). We examined the SNP employed by Hong et al. 46 as well as two additional SNPs. In the total population of SZ we studied, the SNP employed by Hong et al. 46 did not show a statistically significant association with SZ, while there was a significant association with 'disorganized' patients (P = 0.050) after correction for multiple testing. It should be noted that the 'risk' allele over-represented in our cases differs from that identified in the study by Hong et al. 46 In their study, Hong et al. 46 indicate that the 'G' allele may be a risk factor for SZ. In our study, however, the 'A' allele is over-represented in SZ cases. Despite these discrepancies, we speculate that the rs3952 polymorphism may serve as a marker of a 
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K Fujii et al disease mutation rather than being a causative factor. This idea is consistent with the higher significance observed with another SNP (rs2076369) employed in our study (P = 0.080 total samples; P = 0.012 'disorganized' cases). Besides its interactions with protein kinase C, 42, 50 AMPA receptors, 53, 54 and metabotropic glutamate receptors [55] [56] [57] [58] and SR, PICK1 binds to the neuronal membrane transporters for dopamine and norepinephrine. 59 Coexpression of PICK1 with dopamine transporters leads to increased numbers of plasma membrane dopamine transporters and augmented dopamine uptake. Dopamine neurotransmission has been extensively implicated in SZ, as classic neuroleptics act by blocking dopamine D2 receptors while release of dopamine by amphetamines is associated with a worsening of symptoms. [60] [61] [62] Most studies of neurotransmitters in mental illness have focused upon their neuronal disposition. SR and D-serine are formed primarily in glia that ensheath glutamatergic synapses. 7 In the present study we demonstrate PICK1 in glia, where it interacts with SR. Many recent studies have emphasized the importance of glia for regulation of neurotransmission in the brain. 63, 64 Our results suggest that glial disposition of neurotransmitters may be relevant to understanding the pathophysiology of SZ. 
